On Monday, Following U.S. Stocks were among the “Top Gainers”: Cytori Therapeutics, Inc. (NASDAQ:CYTX), Amedica Corporation (NASDAQ:AMDA), MGIC Investment Corp. (NYSE:MTG), Talmer Bancorp, Inc. (NASDAQ:TLMR)
Cytori Therapeutics, Inc. (NASDAQ:CYTX), with shares inclined 14.17%, closed at $1.37.
Amedica Corporation (NASDAQ:AMDA), with shares jumped 13.79%, settled at $0.66.
MGIC Investment Corp. (NYSE:MTG), with shares climbed 3.07%, and closed at $9.74, hitting new 52-week high of $9.83.
Talmer Bancorp, Inc. (NASDAQ:TLMR), surged 3.04%, and closed at $15.27, hitting new 52-week high of $15.62.
Latest NEWS regarding these Stocks are depicted underneath:
Cytori Therapeutics, Inc. (NASDAQ:CYTX)
Cytori Therapeutics, Inc. (CYTX), declared its fourth quarter and year end 2014 business and financial results.
Cytori achieved total proceeds for the year and fourth quarter ended December 31, 2014 of $7.6 million and $3.8 million, respectively, contrast to $12.2 million and $3.5 million, respectively, for the same periods in 2013. Total net loss allocable to ordinary stock holders was $38.5 million in 2014 contrast with $26.2 million in 2013. Cytori ended the year with $14.6 million of cash and cash equivalents.
In addition, Cytori received recently written notification from the NASDAQ Stock Market LLC that it has regained full compliance with the NASDAQ Stock Market Listing Rules concerning the Corporation’s closing bid price, and formerly received written notification indicating the Corporation regained compliance with the NASDAQ Stock Market Listing Rule regarding the market value of listed securities. The Corporation is happy that each of the NASDAQ Stock Market compliance issues we formerly stated in the latter part of 2014 have been resolved.
Cytori Therapeutics, Inc., a cell therapy corporation, develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions.
Amedica Corporation (NASDAQ:AMDA)
Amedica Corporation (AMDA), a corporation that develops and commercializes silicon nitride ceramics as a biomaterial platform, declared that it will host a conference call and live webcast to present the 12-month CASCADE clinical results, a blinded, randomized clinical trial that contrast outcomes of spinal fusion surgery between its composite silicon nitride fusion devices manufactured with a central core of cancellous structured ceramic (CsC), to the industry gold standard, i.e., PEEK (polyether ether ketone plastic) spacers filled with bone autograft.
Mark P. Arts, M.D., Ph.D., Neurosurgeon at the Medical Center Haaglanden, The Hague, Netherlands will present the findings and Dr. Sonny Bal, Chairman and CEO of Amedica Corporation will talk about the potential influence on the business.
Amedica to Host Conference Call on March 24, 2015.
Amedica Corporation, a commercial-stage biomaterial corporation, develops, manufactures, and sells a range of medical devices in the United States. It offers Valeo silicon nitride interbody spinal fusion devices for use in the cervical and thoracolumbar areas of the spine; Valeo stand-alone anterior lumbar intervertebral fusion device; and a line of non-silicon nitride spinal fusion products used by surgeons to promote bone growth and fusion in spinal fusion procedures.
MGIC Investment Corp. (NYSE:MTG)
Formerly on March 9, MGIC Investment Corp. (MTG), issued an Operational Summary of its insurance auxiliaries for the month of February 2015 for their primary mortgage insurance.
MGIC Investment Corporation, through its auxiliaries, provides private mortgage insurance and ancillary services to lenders and government sponsored entities in the United States. At December 31, 2014 MGIC had $164.9 billion of primary insurance in force covering about one million mortgages.
Talmer Bancorp, Inc. (NASDAQ:TLMR)
S&P Dow Jones Indices will make the following changes to the S&P 100, S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:
S&P MidCap 400 constituent Henry Schein Inc. (HSIC) will replace Carefusion Corp. (CFN) in the S&P 500, S&P SmallCap 600 constituent Buffalo Wild Wings Inc. (BWLD) will replace Henry Schein in the S&P MidCap 400, and Talmer Bancorp Inc. (TLMR) will replace Buffalo Wild Wings in the S&P SmallCap 600 after the close of trading on Tuesday, March 17. S&P 500 constituent Becton, Dickinson and Corporation (BDX) is acquiring Carefusion in a deal predictable to be accomplished on or about that date, pending final approvals.
Talmer Bancorp, Inc., through its auxiliaries, provides various commercial and retail banking products and services to small and medium-sized businesses, and individuals in the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
